Влияние системной менопаузальной гормональной терапии на симптомы недержания мочи у женщин в постменопаузе

1. Балан В.Е., Ковалева Л.А. Урогенитальный синдром в климактерии. Возможности терапии. Акушерство и гинекология. 2015; 5: 104-8. 
2. Aoki Y., Brown H.W., Brubaker L., Cornu J.N., Daly J.O., Cartwright R. et al. Urinary incontinence in women. Nat. Rev. Dis. Primers. 2017; 3: 17042.https://dx.doi.org/10.1038/nrdp.2017.42
3. Russo E., Caretto M., Giannini A., Bitzer J., Cano A., Ceausu I. et al. Management of urinary incontinence in postmenopausal women: An EMAS clinical guide. Maturitas. 2021; 143: 223-30. https://dx.doi.org/10.1016/j.maturitas.2020.09.005.
4. Briggs P. Genitourinary syndrome of menopause. Post Reprod. Health. 2020; 26(2): 111-4. https://dx.doi.org/10.1177/2053369119884144.
5. Phillips N.A., Bachmann G.A. The genitourinary syndrome of menopause. Menopause. 2021; 28(5): 579-88. https://dx.doi.org/10.1097/GME.0000000000001728.
6. Marino J.M. Genitourinary syndrome of menopause. J. Midwifery Womens Health. 2021; 66(6): 729-39. https://dx.doi.org/10.1111/jmwh.13277.
7. Ермакова Е.И., Балан В.Е., Тихомирова Е.В., Лазарева И.Н., Лапина А.В., Панина Е.М. Генитоуринарный менопаузальный синдром: диагностика и принципы лечения (краткие клинические рекомендации). Российский вестник акушера-гинеколога. 2017; 17(6): 8995. 
8. Аполихина И.А., Горбунова Е.А. Лечение генитоуринарного синдрома в менопаузе: результаты опроса акушеров-гинекологов в России. Медицинский cовет. 2017; 13: 157-64. 
9. Faubion S.S., Sood R., Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin. Proc. 2017; 92(12): 1842-9. https://dx.doi.org/10.1016/j.mayocp.2017.08.019.
10. Angelou K., Grigoriadis T., Diakosavvas M., Zacharakis D., Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020; 12(4): e7586. https://dx.doi.org/10.7759/cureus.7586.
11. Moral E., Delgado J.L., Carmona F., Caballero B., Guillán C., González P.M. et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018; 21(2): 167-73. https://dx.doi.org/10.1080/13697137.2017.1421921.
12. Sarmento A.C.A., Costa A.P.F., Vieira-Baptista P., Giraldo P.C., Eleutério J. Jr, Gonçalves A.K. Genitourinary syndrome of menopause: epidemiology, physiopathology, clinical manifestation and diagnostic. Front. Reprod. Health. 2021; 3: 779398. https://dx.doi.org/10.3389/frph.2021.779398.
13. Аполихина И.А., Саидова А.С. Стрессовое недержание мочи. Акушерство и гинекология. 2019; 3(приложение): 20-5. 
14. Cunha G.R., Robboy S.J., Kurita T., Isaacson D., Shen J., Cao M. et al. Development of the human female reproductive tract. Differentiation. 2018; 103: 46-65. https://dx.doi.org/10.1016/j.diff.2018.09.001.
15. Capobianco G., Madonia M., Morelli S., Dessole F., De Vita D., Cherchi P.L. et al. Management of female stress urinary incontinence: A care pathway and update. Maturitas. 2018; 109: 32-8. https://dx.doi.org/10.1016/j.maturitas.2017.12.008.
16. The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27(9): 976-92.https://dx.doi.org/10.1097/GME.0000000000001609.
17. Неймарк А.И., Раздорская М.В., Гаджиева З.К. Эстрогенодефицит и недержание мочи у женщин в климактерии. Урология. 2016, 5: 130-7. 
18. Post W.M., Widomska J., Grens H., Coenen M.J.H., Martens F.M.J., Janssen D.A.W. et al. Molecular processes in stress urinary incontinence: a systematic review of human and animal studies. Int. J. Mol. Sci. 2022; 23(6): 3401.https://dx.doi.org/10.3390/ijms23063401.
19. Kuan K.K.W., Saunders P.T.K. Female reproductive systems: hormone dependence and receptor expression. Adv. Exp. Med. Biol. 2022; 1390: 21-39. https://dx.doi.org/10.1007/978-3-031-11836-4_2.
20. Alperin M., Burnett L., Lukacz E., Brubaker L. The mysteries of menopause and urogynecologic health: clinical and scientific gaps. Menopause. 2019; 26(1): 103-11. https://dx.doi.org/10.1097/GME.0000000000001209.
21. Kagan R., Kellogg-Spadt S., Parish S.J. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019; 36(10): 897-908. https://dx.doi.org/10.1007/s40266-019-00700-w.
22. Rahkola-Soisalo P., Savolainen-Peltonen H., Gissler M., Hoti F., Vattulainen P., Ylikorkala O. et al. Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy. Int. Urogynecol. J. 2019; 30(2): 251-6. https://dx.doi.org/10.1007/s00192-018-3682-7.
23. Biehl C., Plotsker O., Mirkin S. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause. 2019; 26(4): 431-53. https://dx.doi.org/10.1097/GME.0000000000001221.
24. Iliodromiti S., Wang W., Lumsden M.A., Hunter M.S., Bell R., Mishra G. et al. Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG. 2020; 127(3): 320-33.https://dx.doi.org/10.1111/1471-0528.15990.
25. Аполихина И.А., Беженарь В.Д., Попов А.А., Балан В.Е., Петрова В.Д., Коршунов М.Ю., Назарова Н.М., Краснопольская И.В., Ермакова Е.И., Саидова А.С. Резолюция по итогам Совещания экспертов по лечению гиперактивного мочевого пузыря. Акушерство и гинекология. 2019; 3(приложение): 30-1. 
26. Lethaby A., Ayeleke R.O., Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst. Rev. 2016; 2016(8): CD001500. https://dx.doi.org/10.1002/14651858.CD001500.
27. Todhunter-Brown A., Hazelton C., Campbell P., Elders A., Hagen S., McClurg D. Conservative interventions for treating urinary incontinence in women: an overview of cochrane systematic reviews. Cochrane Database Syst. Rev. 2022; 9(9): CD012337. https://dx.doi.org/10.1002/14651858.CD012337.
28. Nemirovsky A., Villela NA., Yuan J.C., Patil R., Malik R.D. Vaginal hormone therapy for conditions of the lower urinary tract. Curr. Urol. Rep. 2023; 24(2): 41-50. https://dx.doi.org/10.1007/s11934-022-01132-7.
29. Balk E.M., Rofeberg V.N., Adam G.P., Kimmel H.J., Trikalinos T.A., Jeppson P.C. Pharmacologic and nonpharmacologic treatments for urinary incontinence in women: a systematic review and network meta-analysis of clinical outcomes. Ann. Intern. Med. 2019; 170(7): 465-79. https://dx.doi.org/10.7326/M18-3227.
30. Zhang G.Q., Chen J.L., Luo Y., Mathur M.B., Anagnostis P., Nurmatov U. et al. Menopausal hormone therapy and women’s health: an umbrella review. PLoS Med. 2021; 18(8): e1003731. https://dx.doi.org/10.1371/journal.pmed.1003731.
31. Steinauer J.E., Waetjen L.E., Vittinghoff E., Subak L.L., Hulley S.B., Grady D. et al. Postmenopausal hormone therapy: does it cause incontinence? Obstet. Gynecol. 2005; 106(5, Pt 1): 940-5. https://dx.doi.org/10.1097/01.AOG.0000180394.08406.15.
32. Edwall L., Carlström K., Jonasson A.F. Different estrogen sensitivity of urogenital tissue from women with and without stress urinary incontinence. Neurourol. Urodyn. 2009; 28(6): 516-20. https://dx.doi.org/10.1002/nau.20710.

Поступила 10.02.2023

Принята в печать 30.05.2023